| Metabolism of salicylic acid in wild‐type, ugt74f1 and ugt74f2 glucosyltransferase mutants of Arabidopsis thaliana JV Dean, SP Delaney Physiologia plantarum 132 (4), 417-425, 2008 | 180 | 2008 |
| The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis SP Delaney, LM Julian, WL Stanford Frontiers in cell and developmental biology 2, 69, 2014 | 44 | 2014 |
| Integrative genomics positions MKRN 1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network PA Cassar, RL Carpenedo, P Samavarchi‐Tehrani, JB Olsen, CJ Park, ... EMBO reports 16 (10), 1334-1357, 2015 | 37 | 2015 |
| Human Pluripotent Stem Cell–Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis LM Julian, SP Delaney, Y Wang, AA Goldberg, C Doré, J Yockell-Lelièvre, ... Cancer research 77 (20), 5491-5502, 2017 | 33 | 2017 |
| Public solicitation of anonymous organ donors: a position paper by the Canadian Society of Transplantation MC Fortin, D Buchman, L Wright, J Chandler, S Delaney, T Fairhead, ... Transplantation 101 (1), 17-20, 2017 | 29 | 2017 |
| Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance M Kaliszczak, H Patel, SHB Kroll, L Carroll, G Smith, S Delaney, ... British journal of cancer 109 (9), 2356-2367, 2013 | 24 | 2013 |
| Current state of stem cell-mediated therapies for facial nerve injury TV Wang, S Delaney, JP Pepper Current Opinion in Otolaryngology & Head and Neck Surgery 24 (4), 285-293, 2016 | 15 | 2016 |
| Human pluripotent stem cell modeling of tuberous sclerosis complex reveals lineage-specific therapeutic vulnerabilities SP Delaney, LM Julian, A Pietrobon, J Yockell-Lelièvre, C Doré, TT Wang, ... Available at SSRN 3554075, 2020 | 10 | 2020 |
| Canadian Society of Transplantation white paper: ethical and legal considerations for alcohol and cannabis use in solid organ listing and allocation R Greenberg, A Goldberg, S Anthony, DZ Buchman, S Delaney, V Gruben, ... Transplantation 105 (9), 1957-1964, 2021 | 8 | 2021 |
| The effect of a chimeric mouse-human CD7 antibody on human T, natural killer, and lymphokine-activated killer cell activity in vitro AN AKBAR, PL AMLOT, C HAWKINS, W NEwsHoLME, S DELANEY, ... Transplantation 52 (2), 325-330, 1991 | 5 | 1991 |
| Could immunotherapy sink its teeth into lymphangioleiomyomatosis? A Pietrobon, SP Delaney, WL Stanford American Journal of Respiratory Cell and Molecular Biology 59 (6), 663-665, 2018 | 2 | 2018 |
| Differential and lasting gene expression changes in circulating CD8 T cells in chronic HCV infection with cirrhosis and related insights on the role of Hedgehog signaling J Li, A Vranjkovic, D Read, SP Delaney, WL Stanford, CL Cooper, ... bioRxiv, 2023.09. 20.557725, 2023 | 1 | 2023 |
| Waitlisted and transplant patient perspectives on expanding access to deceased-donor kidney transplant: A qualitative study C Rosaasen, N Rosaasen, R Mainra, A Trachtenberg, J Ho, C Parsons, ... Canadian Journal of Kidney Health and Disease 9, 20543581221100291, 2022 | 1 | 2022 |
| Tissue‐Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition A Pietrobon, J Yockell‐Lelièvre, N Melong, LJ Smith, SP Delaney, ... Advanced Science 10 (26), 2302611, 2023 | | 2023 |
| Waitlisted and Transplant Patient Perspectives on Expanding Access to Deceased Donor Kidney Transplants. C Rosaasen, N Rosaasen, R Mainra, A Trachtenberg, J Ho, C Parsons, ... AMERICAN JOURNAL OF TRANSPLANTATION 22, 658-658, 2022 | | 2022 |
| Three-dimensional drug screen identifies HDAC inhibitors as therapeutic agents in mTORC1-driven lymphangioleiomyomatosis A Pietrobon, J Yockell-Lelièvre, N Melong, LJ Smith, SP Delaney, ... bioRxiv, 2021.07. 03.451004, 2021 | | 2021 |
| Loss of TSC1 or TSC2 drives lineage infidelity and hamartoma formation in a renal organoid model of angiomyolipoma A Pietrobon, SP Delaney, C Doré, J Yockell-Lelievre, L Julian, ... Cancer Research 81 (13_Supplement), 2974-2974, 2021 | | 2021 |
| High throughput small molecule screening with synthetic 3D lung-mimetic hydrogels in the rare lung cancer lymphangioleiomyomatosis A Pietrobon, J Yockell-Lelievre, C Doré, RY Tam, SP Delaney, M Shoichet, ... Cancer Research 80 (16_Supplement), 6316-6316, 2020 | | 2020 |
| Modeling and therapeutic development for the tuberous sclerosis related neoplasm lymphangioleiomyomatosis SP Delaney Université d'Ottawa/University of Ottawa, 2019 | | 2019 |
| P010 Higher definition CPRA: What’s the (decimal) point? K Tinckam, K Maru, N Lahaie, M Gillissie, M Mousseau, S Delaney, ... Human Immunology 78, 61-62, 2017 | | 2017 |
